
News|Articles|January 2, 2024
Accelerating Cell Culture Media Manufacturing From Rapid Prototyping Through cGMP (Jan 2024)
Author(s)Thermo Fisher Scientific
The importance of successfully scaling up cell culture media cannot be overstated. Not starting the process soon enough can introduce issues with solubility, manufacturability, procurement, and cost management. This article considers technical and commercial best practices that drug developers may enact so that they, their suppliers and media manufacturers, and in turn, their cell culture media remain on the most efficient path to market.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
How the Wegovy Pill Approval Reshapes Solid Dosage Manufacturing Strategy
2
Innovation and Market Exclusivity in the EU
3
FDA Approval of Cytokinetics’ Myqorzo Reflects Specialty Cardio Drug Trend
4
Harnessing Data and Secure Cloud Environments for Global Pharma Solutions
5